Method for eye lens removal using cavitating microbubbles

US11844724B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11844724-B2
Application numberUS-202117509641-A
CountryUS
Kind codeB2
Filing dateOct 25, 2021
Priority dateJan 4, 2019
Publication dateDec 19, 2023
Grant dateDec 19, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A surgical method of cataract fragmentation and extraction via microbubble cavitation is described. In particular, gas-filled microbubbles are injected into a lens capsule of a subject's eye, and cavitation of the microbubbles is activated by applied ultrasound energy. The ultrasound energy can be applied from an external device. The cavitation fragments cataract tissues without damaging other tissue, such as the lens capsule. Fragmented lens material is then aspirated from the lens capsule. The method can be used alone or in conjunction with other methods, such as phacoemulsification.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for removing a lens from an eye, the method comprising: injecting microbeads into the eye of a subject; directing energy at the injected microbeads sufficient to cause the microbeads to undergo cavitation; fragmenting lens material of the eye with the cavitation; and aspirating the fragmented lens material from the eye. 2. The method of claim 1 further comprising: repeating the injecting, directing, fragmenting, and aspirating to remove the entire lens from the subject. 3. The method of claim 1 wherein each of the microbeads is comprised of: a phospholipid shell; and a fluorinated alkane gas inside the phospholipid shell. 4. The method of claim 3 wherein the fluorinated alkane gas is selected from the group consisting of perfluoropropane and butane. 5. The method of claim 1 wherein each of the microbeads is comprised of: a block copolymer or functionalized natural polymer shell; and a fluorocarbon gas inside the shell. 6. The method of claim 1 wherein each of the microbeads is comprised of: a multiphase polymer shell; and air inside the shell. 7. The method of claim 1 wherein the microbeads are coated with a targeting moiety configured to bind to the lens material, the method further comprising: binding the microbeads to the lens material of the lens. 8. The method of claim 7 wherein the targeting moiety comprises polypeptides or acidic groups. 9. The method of claim 1 further comprising: performing a capsulorhexis on the eye; hydrodissecting the lens from the eye; and inserting an artificial intraocular lens into the eye. 10. The method of claim 9 wherein the injecting of the microbeads is performed with hydrodissecting liquid. 11. The method of claim 1 wherein the microbeads are in a liquid suspension, and the injecting includes injecting the liquid suspension into the eye. 12. The method of claim 11 wherein the liquid suspension is used to irrigate the eye. 13. The method of claim 1 wherein the microbeads are injected into or around the lens. 14. The method of claim 1 wherein the energy reaches the microbeads by being transmitted through biological tissue from outside of the eye. 15. The method of claim 1 wherein the energy is transmitted from within the eye using an ultrasonic tip. 16. The method of claim 1 further comprising: inserting a phacoemulsification handpiece tip into the eye; and emulsifying, during or after the fragmenting, the lens material using emulsifying energy transmitted from the phacoemulsification handpiece tip within the eye, wherein less emulsifying energy from the phacoemulsification handpiece tip inside the eye is required to remove the lens than if the fragmenting with the cavitation were not performed. 17. The method of claim 1 wherein the subject is one or more of: a human; a dog; or a rabbit. 18. The method of claim 1 wherein the microbeads are injected into a lens capsule of the eye. 19. A system for removing a lens from an eye of a subject, the system comprising: stabilized gas-filled microbeads having an outside diameter less than 500 microns, wherein the stabilized gas-filled microbeads are suitable for injecting into the eye and configured to undergo cavitation when subjected to ultrasound energy; a microbubble activation instrument configured to direct ultrasound energy to the injected stabilized gas-filled microbeads sufficient to cause the microbeads to undergo cavitation and fragment lens material with the cavitation while preserving a lens capsule of the eye. 20. The system of claim 19 wherein the microbubble activation instrument includes: an ultrasonic tip for transmitting the ultrasound energy from within the eye; or a phacoemulsification handpiece tip for inserting into the eye.

Assignees

Inventors

Classifications

  • using mechanical vibrations, e.g. ultrasonic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11844724B2 cover?
A surgical method of cataract fragmentation and extraction via microbubble cavitation is described. In particular, gas-filled microbubbles are injected into a lens capsule of a subject's eye, and cavitation of the microbubbles is activated by applied ultrasound energy. The ultrasound energy can be applied from an external device. The cavitation fragments cataract tissues without damaging other …
Who is the assignee on this patent?
California Inst Of Techn, Univ California, Us Gov Represented By The Department Of Veterans Affairs
What technology area does this patent fall under?
Primary CPC classification A61F9/00745. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).